Causality of the gut microbiome and atherosclerosis-related lipids: a bidirectional Mendelian Randomization study

[1] Mensah GA(2019)The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond J Am Coll Cardiol 74 2529-2532

[2] Roth GA(2021)Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association Circulation 143 e254-e743

[3] Fuster V(2009)Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 1993-2000

[4] Virani SS(2007)Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies Circulation 115 450-458

[5] Alonso A(2009)Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 412-423

[6] Aparicio HJ(2018)Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients Pak J Med Sci 34 247-252

[7] Di Angelantonio E(2001)Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis Physiol Res 50 337-343

[8] Sarwar N(2001)Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 21 1023-1028

[9] Perry P(2019)Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes Cells 8 319-170

[10] Sarwar N(2021)Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review Curr Cardiol Rev 17 e051121189015-921

[1] Mensah GA(2019)The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond J Am Coll Cardiol 74 2529-2532

[2] Roth GA(2021)Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association Circulation 143 e254-e743

[3] Fuster V(2009)Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 1993-2000

[4] Virani SS(2007)Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies Circulation 115 450-458

[5] Alonso A(2009)Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 412-423

[6] Aparicio HJ(2018)Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients Pak J Med Sci 34 247-252

[7] Di Angelantonio E(2001)Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis Physiol Res 50 337-343

[8] Sarwar N(2001)Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 21 1023-1028

[9] Perry P(2019)Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes Cells 8 319-170

[10] Sarwar N(2021)Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review Curr Cardiol Rev 17 e051121189015-921